Protalix Biotherapeutics, Inc. (de) · AMEX:PLX
Protalix Biotherapeutics, Inc. (de) shareholders
As of Jun 30, 2026, 100 institutions reported holding Protalix Biotherapeutics, Inc. (de), 17.9% of its shares. Largest: BlackRock, Renaissance Technologies and State Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Protalix Biotherapeutics, Inc. (de) | Change | Filed |
|---|---|---|---|---|
| BlackRock | 4.05M | 5.0% | +430K | Aug 7, 2026 |
| Renaissance Technologies | 1.1M | 1.4% | −129K | Aug 13, 2026 |
| State Street | 984K | 1.2% | +10,767 | Aug 7, 2026 |
| Geode Capital | 980K | 1.2% | +115K | Aug 12, 2026 |
| Northern Trust | 922K | 1.1% | +36,892 | Aug 13, 2026 |
| Vanguard | 581K | 0.72% | +85,080 | Aug 13, 2026 |
| Stratos Wealth Partners, LTD. | 500K | 0.62% | no change | Aug 11, 2026 |
| Dimensional | 493K | 0.61% | +197K | Aug 11, 2026 |
| Goldman Sachs | 476K | 0.59% | +225K | Aug 14, 2026 |
| Marshall Wace, LLP | 453K | 0.56% | new | Aug 13, 2026 |